Insights

Collaborations Expansion Cibus is actively pursuing partnerships to accelerate adoption of its gene-editing platform, notably with Crystal Crop Protection in India to bring improved mustard seeds to growers faster, signaling a ripe opportunity for regional distributors and seed companies.

Regulatory Validation EU recognition that crops improved without foreign DNA can be treated like conventionally bred crops reinforces market access and reduces regulatory risk, creating a favorable environment for scaled commercialization and partnerships in Europe and beyond.

Sustainable Ingredients The company emphasizes sustainable ingredient production and rice launches in Latin America, presenting cross-sell prospects to agribusinesses and food manufacturers seeking low-input, high-efficiency crop solutions.

Financial Signals Revenue in the low single digits with a significant funding runway suggests potential for strategic partnerships or licensing deals to monetize technology while continuing R&D, appealing to investors and corporate partners seeking early-stage biotech collaborations.

Global Market Readiness Recent press highlights indicate readiness for international deployment, particularly in Asia and EU regions, indicating sales motion should target regional agritech distributors, seed companies, and cooperative farming networks seeking faster access to improved seed traits.

Similar companies to Cibus

Cibus Tech Stack

Cibus uses 8 technology products and services including Google AdSense, Power BI, Tableau, and more. Explore Cibus's tech stack below.

Media & News

Cibus's Email Address Formats

Cibus uses at least 4 email formats:
Cibus Email FormatsExamplePercentage
FLast@cibus.comJDoe@cibus.com
79%
Last@cibus.comDoe@cibus.com
8%
First.Last@cibus.comJohn.Doe@cibus.com
7%
First@cibus.comJohn@cibus.com
6%

Frequently Asked Questions

What is Cibus's phone number?

Minus sign iconPlus sign icon
You can contact Cibus's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cibus's stock symbol?

Minus sign iconPlus sign icon
Cibus is a publicly traded company; the company's stock symbol is CBUS.

What is Cibus's official website and social media links?

Minus sign iconPlus sign icon
Cibus's official website is cibus.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Cibus generate?

Minus sign iconPlus sign icon
As of October 2026, Cibus's annual revenue is estimated to be $1M - $10M.

What is Cibus's SIC code and NAICS code?

Minus sign iconPlus sign icon
Cibus's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cibus have currently?

Minus sign iconPlus sign icon
As of October 2026, Cibus has approximately 320 employees across 5 continents, including North America, Europe and South America. Key team members include Vp Finance & Business Development: G. P., Vice President Finance: G. P. and President: J. L. Explore Cibus's employee directory with LeadIQ.

What industry does Cibus belong to?

Minus sign iconPlus sign icon
Cibus operates in the Biotechnology Research industry.

What technology does Cibus use?

Minus sign iconPlus sign icon
Cibus's tech stack includes Google AdSense, Power BI, Tableau, Webflow, Puppet, Paylocity, Microsoft Teams and Adobe Creative Suite.

What is Cibus's email format?

Minus sign iconPlus sign icon
Cibus's email format typically follows the pattern of FLast@cibus.com. Find more Cibus email formats with LeadIQ.

How much funding has Cibus raised to date?

Minus sign iconPlus sign icon
As of October 2026, Cibus has raised $262M in funding. The last funding round occurred on Mar 26, 2026 for $28M.

When was Cibus founded?

Minus sign iconPlus sign icon
Cibus was founded in 2001.
Cibus logo

Cibus

Biotechnology ResearchCalifornia, United States201-500 Employees

Cibus is a biotechnology research company based in San Diego, California, with 201-500 employees. The company develops technologies to precisely target and direct a plant's natural gene-editing processes to support traditional breeding methods used in agriculture. It develops and licenses plant traits to seed companies, placing its work in the agricultural technology landscape. In 2026, the company announced leadership changes with Craig Wichner appointed Chief Executive Officer and Peter Beetham continuing as President and Chief Operating Officer, while both Wichner and Beetham resigned from the Board as part of the reorganization. Funding is reported at about $28 million, with quarterly revenue in the range of $1 million to $10 million.

Section iconCompany Overview

Phone number
Website
cibus.com
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CBUS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2001
Employees
201-500

Section iconFunding & Financials

  • $262M

    Cibus has raised a total of $262M of funding over 10 rounds. Their latest funding round was raised on Mar 26, 2026 in the amount of $28M as a Post IPO Equity.

  • $1M - $10M

    Cibus's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.